Table 1. Clinical features of the 78 patient before treatments in our hospital.
Characteristics | NO. (Ratio) or Mean (Range) |
---|---|
Age | 26.5 (16-38) |
Gravidity | 2.0 (1-6) |
Parity time | |
0 | 63 (80.8%) |
1 | 12 (15.4%) |
2 | 3 (3.8%) |
Pretreatment β-HCG (IU/L) | 154873.2 (15.5-3508811) |
FIGO score | |
≤6 | 43 (55.1%) |
≥7 | 35 (44.9%) |
FIGO stage | |
I | 42 (53.9%) |
II | 1 (1.3%) |
III | 31 (39.7%) |
IV | 4 (5.1%) |
Metastasis | |
Lung | 34 (43.6%) |
Liver | 2 (2.6%) |
Brain | 1 (1.3%) |
Vagina | 1 (1.3%) |
Pelvic wall | 1 (1.3%) |
Previous GTN history | |
NO | 70 (89.7%) |
YES | 8 (10.3%) |
Resistant to multi-drug chemotherapy | |
NO | 68 (87.2%) |
YES | 10 (12.8%) |